Apellis Pharmaceuticals: Strategic Advantage and Market Potential Boost with Syfovre’s Competitive Edge
J.P. Morgan analyst Anupam Rama has maintained their bullish stance on APLS stock, giving a Buy rating on November 7.Don't Miss our Black ...